USPTO rules Broad owns CRISPR animal cell editing patents
01-03-2022
EPO Board of Appeal issues communication on BI CRISPR/Cas9 patent hearing
04-11-2019
EPO grants second CRISPR patent to ERS Genomics
07-03-2018
vchal / iStockphoto.com
The Broad Institute of Harvard and MIT has said it will appeal against a decision by the European Patent Office (EPO) to revoke one of its patents covering CRISPR/Cas9 technology.
To continue reading this article and to access our full archive, digital magazines and special reports you will need a subscription.
Start a subscription today to access the LSIPR website
If you have already subscribed please login.
For multi-user price options, or to check if your company has an existing subscription we can add you into, please email Atif at achoudhury@newtonmedia.co.uk
If you have any technical issues please email tech support.
For access to the complete website and archive choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial select ‘TWO WEEK FREE TRIAL’.
Broad Institute, CRISPR, patent revocation, EPO, European Patent Office
